Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Philippines Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20065
20072
20082
20095
20103
20111
20142
20154
20161
20173
20186
20192
20203
20214
20222
20235
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Active, not recruiting12
Terminated6
Recruiting3
No longer available1
Approved for marketing1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
Merck Sharp & Dohme LLC6
Boehringer Ingelheim4
Genzyme, a Sanofi Company3
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Pfizer2
AVEO Pharmaceuticals, Inc.1
Agennix1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung59
Lung Neoplasms10
Carcinoma6
Neoplasm Metastasis4
Neoplasms3
Adenocarcinoma2
Adenocarcinoma of Lung2
Lung Diseases2
Adenoma, Islet Cell1
Anemia1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.